Kura Oncology, Inc. (KURA)
NASDAQ: KURA · IEX Real-Time Price · USD
20.95
-0.55 (-2.56%)
At close: Jul 19, 2024, 4:00 PM
20.87
-0.08 (-0.38%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Kura Oncology Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Kura Oncology stock have an average target of 28.36, with a low estimate of 10.5 and a high estimate of 37. The average target predicts an increase of 35.37% from the current stock price of 20.95.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Kura Oncology stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 3 | 3 |
Buy | 4 | 4 | 4 | 3 | 3 | 3 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 10 | 10 | 10 | 9 | 7 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +52.74% | Jun 24, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $32 | Buy | Reiterates | $32 | +52.74% | Jun 18, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $32 | Buy | Reiterates | $32 | +52.74% | May 16, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | May 14, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $32 | Buy | Reiterates | $32 | +52.74% | May 6, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
11.89M
EPS This Year
-2.58
from -2.08
EPS Next Year
-2.72
from -2.58
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | 44.3M | 473.8M | 1.7B | 979.5M |
Avg | n/a | 11.9M | 138.6M | 337.6M | 416.3M |
Low | n/a | n/a | 7.6M | 21.4M | 44.0M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | 3,883.5% | 1,103.8% | 190.1% |
Avg | - | - | 1,065.7% | 143.5% | 23.3% |
Low | - | - | -35.7% | -84.6% | -87.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -2.48 | -2.13 | 1.27 | 8.24 | 4.44 |
Avg | -2.58 | -2.72 | -2.10 | -0.37 | 0.09 |
Low | -2.81 | -2.88 | -3.31 | -3.78 | -1.96 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.